Target Name: LOC101930053
NCBI ID: G101930053
Review Report on LOC101930053 Target / Biomarker Content of Review Report on LOC101930053 Target / Biomarker
LOC101930053
Other Name(s): uncharacterized LOC101930053 | LOC101930053 variant X5 | Uncharacterized LOC101930053, transcript variant X5

A closer look at LOC101930053: A Potential Drug Target and Biomarker

LOC101930053 is a gene that has garnered significant attention in the scientific community due to its involvement in various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its unique structure and various bioactive compounds have led researchers to investigate its potential as a drug target or biomarker. In this article, we will provide a comprehensive overview of LOC101930053, including its structure, bioactivity, and potential applications in drug development.

Structure and Bioactivity

LOC101930053 is a single-copy gene located on chromosome 19q15. Its primary structure consists of a 194 base pair long DNA sequence that encodes a protein known as LOC101930053 protein (LOC101930053p). The protein is composed of 216 amino acids and has a calculated molecular weight of 21.1 kDa. LOC101930053p is expressed in various cell types and tissues, including human placenta, brain, and cancer samples.

The bioactivity of LOC101930053p has been evaluated using various assays, including cell-based assays, in vitro assays, and animal models. results from these studies have demonstrated that LOC101930053p can interact with various protein targets, including tyrosine kinase, G-protein-coupled receptor, and nuclear factor kappa B. Additionally, LOC101930053p has been shown to play a role in various biological processes, including cell growth, apoptosis, and inflammation.

Potential Applications

The potential applications of LOC101930053p as a drug target or biomarker are vast and varied. As a drug target, LOC101930053p could potentially be developed into a therapy for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. For example, LOC101930053p has been shown to inhibit the androgen-induced increase in cell proliferation in prostate cancer cells. Additionally, LOC101930053p has been shown to interact with various protein targets that are involved in neurodegenerative disorders, providing new insights into the pathophysiology of these conditions.

As a biomarker, LOC101930053p could potentially be used as a diagnostic or predictive tool for various diseases. For example, LOC101930053p has been shown to be expressed in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, LOC101930053p has been shown to be involved in various biological processes, including cell apoptosis, providing a potential window into the pathophysiology of various diseases.

Conclusion

LOC101930053 is a gene that has significant potential as a drug target or biomarker. Its unique structure and various bioactive compounds have led to a wealth of research into its involvement in various diseases. Further studies are needed to fully understand the potential applications of LOC101930053p and its potential as a therapy or diagnostic tool.

Protein Name: Uncharacterized LOC101930053

The "LOC101930053 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC101930053 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC101930071 | LOC101930098 | LOC101930112 | LOC101930129 | LOC101930496 | LOC102723311 | LOC102723313 | LOC102723321 | LOC102723323 | LOC102723340 | LOC102723341 | LOC102723342 | LOC102723345 | LOC102723364 | LOC102723370 | LOC102723376 | LOC102723403 | LOC102723409 | LOC102723439 | LOC102723446 | LOC102723475 | LOC102723490 | LOC102723493 | LOC102723517 | LOC102723536 | LOC102723553 | LOC102723560 | LOC102723564 | LOC102723566 | LOC102723568 | LOC102723576 | LOC102723596 | LOC102723639 | LOC102723686 | LOC102723692 | LOC102723724 | LOC102723739 | LOC102723750 | LOC102723769 | LOC102723834 | LOC102723838 | LOC102723850 | LOC102723878 | LOC102723890 | LOC102723906 | LOC102723911 | LOC102723914 | LOC102723944 | LOC102723961 | LOC102724001 | LOC102724012 | LOC102724019 | LOC102724023 | LOC102724034 | LOC102724036 | LOC102724058 | LOC102724080 | LOC102724081 | LOC102724087 | LOC102724104 | LOC102724122 | LOC102724137 | LOC102724142 | LOC102724145 | LOC102724192 | LOC102724229 | LOC102724288 | LOC102724322 | LOC102724355 | LOC102724428 | LOC102724429 | LOC102724434 | LOC102724438 | LOC102724467 | LOC102724497 | LOC102724511 | LOC102724520 | LOC102724527 | LOC102724528 | LOC102724542 | LOC102724551 | LOC102724572 | LOC102724594 | LOC102724632 | LOC102724642 | LOC102724653 | LOC102724682 | LOC102724684 | LOC102724719 | LOC102724748 | LOC102724761 | LOC102724768 | LOC102724778 | LOC102724785 | LOC102724786 | LOC102724790 | LOC102724802 | LOC102724808 | LOC102724849 | LOC102724889